OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will give a corporate presentation and update at the Sixth Annual Craig-Hallum Alpha Select Conference being held at the Convene Conference Center in New York City. Transgenomic’s President and Chief Executive Officer Paul Kinnon will present on Thursday, September 17, 2015 at 3:30 PM ET and will also be available for one-on-one meetings.
Help employers find you! Check out all the jobs and post your resume.
